To what extent can dual inhibition of TRPV1 (Transient Receptor Potential Vanilloid-1) and PTGS2 (Prostaglandin- Endoperoxide Synthase 2) be achieved to alleviate pain in patients with refractory primary dysmenorrhea? - Yuqi He (Health and Molecular Frontiers, 2026)